602 related articles for article (PubMed ID: 23390912)
1. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
[TBL] [Abstract][Full Text] [Related]
2. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
Punpanich W; Munsrichoom A; Srisarang S; Treeratweeraphong V
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
[TBL] [Abstract][Full Text] [Related]
6. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
Ozseven AG; Sesli Çetin E; Ozseven L
Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of sulbactam and colistin/sulbactam efficacy against multiple resistant Acinetobacter baumannii blood isolates.
Heydarlou MM; Durmaz G; Ibrahi M BMS
Indian J Med Microbiol; 2022; 40(4):567-571. PubMed ID: 35817630
[TBL] [Abstract][Full Text] [Related]
8. In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
Shafiee F; Naji Esfahani SS; Hakamifard A; Soltani R
Indian J Med Microbiol; 2021 Jul; 39(3):358-362. PubMed ID: 33906750
[TBL] [Abstract][Full Text] [Related]
9. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B
J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii.
Temocin F; Erdinc FS; Tulek N; Demirelli M; Ertem G; Kinikli S; Koksal E
Braz J Microbiol; 2015; 46(4):1119-24. PubMed ID: 26691470
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
Thamlikitkul V; Tiengrim S
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
[TBL] [Abstract][Full Text] [Related]
12. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
[TBL] [Abstract][Full Text] [Related]
13. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
[TBL] [Abstract][Full Text] [Related]
14. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
Dong X; Chen F; Zhang Y; Liu H; Liu Y; Ma L
J Antibiot (Tokyo); 2014 Sep; 67(9):677-80. PubMed ID: 25095805
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
[TBL] [Abstract][Full Text] [Related]
17. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant
Abdel Halim RM; Saber SM; Fahim NAE
J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530
[No Abstract] [Full Text] [Related]
20. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
